Cargando…

The Course of Mild and Moderate COVID-19 Infections—The Unexpected Long-Lasting Challenge

BACKGROUND: The course of disease in mild and moderate COVID-19 has many implications for mobile patients, such as the risk of spread of the infection, precautions taken, and investigations targeted at preventing transmission. METHODS: Three hundred thirty-one adults were hospitalized from January 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Lu, Chen, Jun, Friedemann, Thomas, Yang, Zongguo, Ling, Yun, Liu, Xuhui, Lu, Shuihua, Li, Tao, Song, Zhigang, Huang, Wei, Lu, Yunfei, Schröder, Sven, Lu, Hongzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454824/ https://www.ncbi.nlm.nih.gov/pubmed/32929402 http://dx.doi.org/10.1093/ofid/ofaa286

Ejemplares similares

Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study
por: XIA, Lu, et al.
Publicado: (2021)

Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection
por: Liu, Xuhui, et al.
Publicado: (2013)

Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19
por: Chen, Jun, et al.
Publicado: (2020)

Observations about symptomatic and asymptomatic infections of 494 patients with COVID-19 in Shanghai, China
por: Mei, Xue, et al.
Publicado: (2020)

Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time
por: Rodebaugh, Thomas L, et al.
Publicado: (2021)

Utility of recombinant fusion protein ESAT6-CFP10 skin test for differential diagnosis of active tuberculosis: A prospective study
por: Yuan, Yuan, et al.
Publicado: (2023)

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
por: Kim, Jin Yong, et al.
Publicado: (2022)

Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
por: Hammarström, Helena, et al.
Publicado: (2022)

A Retrospective Forensic Review of Unexpected Infectious Deaths
por: Sehgal, Prateek, et al.
Publicado: (2019)

Factors associated with loss to follow-up before and after treatment initiation among patients with tuberculosis: A 5-year observation in China
por: Jiang, Youli, et al.
Publicado: (2023)

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19
por: Moser, Carlee, et al.
Publicado: (2022)

Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial
por: Moya, Jaynier, et al.
Publicado: (2023)

Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort
por: Laake, Ida, et al.
Publicado: (2022)

Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study
por: Mukae, Hiroshi, et al.
Publicado: (2022)

Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019
por: Streinu-Cercel, Anca, et al.
Publicado: (2022)

A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19
por: Fu, Weihui, et al.
Publicado: (2020)

Increased Diagnostic Yield of Tuberculous Serositis by Using Serous Fluid Drainage Flocky Precipitate (SFDFP) as a Testing Sample
por: Liu, Xuhui, et al.
Publicado: (2019)

Long-Lasting Transcriptional Changes in Circulating Monocytes of Acute Q Fever Patients
por: Raijmakers, Ruud Ph, et al.
Publicado: (2019)

Thalidomide in the treatment of human immunodeficiency virus-negative tuberculous meningitis: A case report
por: Liu, Ping, et al.
Publicado: (2020)

Sensitivity, Specificity, and Safety of a Novel ESAT6-CFP10 Skin Test for Tuberculosis Infection in China: 2 Randomized, Self-Controlled, Parallel-Group Phase 2b Trials
por: Xu, Miao, et al.
Publicado: (2021)

Adult-onset Mendelian Susceptibility to Mycobacterial Diseases: A case report and systematic literature review
por: Yang, Yang, et al.
Publicado: (2023)

Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials
por: Yang, Zongguo, et al.
Publicado: (2014)

Middle East respiratory syndrome coronavirus in the last two years: Health care workers still at risk
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2019)

Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C
por: Khera, Tanvi, et al.
Publicado: (2021)

Short-Course Versus Prolonged-Course Antimicrobial Therapy in Adults With Catheter-Related Septic Thrombosis: A Propensity-Weighted Retrospective Study
por: Stoldick, Marine, et al.
Publicado: (2023)

Operational Evaluation of the Effectiveness of Long-lasting Insecticidal Nets on Human-Vector Contact in an African Urban Malaria Context
por: Traoré, Dipomin F, et al.
Publicado: (2020)

Erythema Migrans: Course and Outcome in Patients Treated With Rituximab
por: Maraspin, Vera, et al.
Publicado: (2019)

Influence of Mild White Matter Lesions on Voxel-based Morphometry
por: Goto, Masami, et al.
Publicado: (2020)

Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
por: Ison, Michael G, et al.
Publicado: (2023)

Tweeting about measles during stages of an outbreak: A semantic network approach to the framing of an emerging infectious disease
por: Tang, Lu, et al.
Publicado: (2018)

Clinical Features and Factors Associated with Outcomes of Patients Infected with a Novel Influenza A (H7N9) Virus: A Preliminary Study
por: Chen, Xiaorong, et al.
Publicado: (2013)

Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis
por: Yang, Zongguo, et al.
Publicado: (2016)

The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis
por: Zhang, Yuan, et al.
Publicado: (2020)

Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) overexpression in tumors predicts worse overall survival in hepatocellular carcinoma
por: Shi, Jia, et al.
Publicado: (2019)

The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study
por: Blair, Paul W, et al.
Publicado: (2021)

Paeoniflorin regulates macrophage activation in dimethylnitrosamine-induced liver fibrosis in rats
por: Chen, Xiaorong, et al.
Publicado: (2012)

RasGRP Exacerbates Lipopolysaccharide-Induced Acute Kidney Injury Through Regulation of ERK Activation
por: Tang, Wen, et al.
Publicado: (2022)

Prognosis of 18 H7N9 Avian Influenza Patients in Shanghai
por: Lu, Shuihua, et al.
Publicado: (2014)

Evaluation of disinfection procedures in a designated hospital for COVID-19
por: Ge, Tianxiang, et al.
Publicado: (2021)

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes( )
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tk2r2llad9sd312r81k78tkmmv